"Dementia Neurodegeneration Network Ireland (DNNI) seeks to improve our understanding of the causes and mechanisms of dementia and neurodegeneration, the effectiveness of different models of care and the policy changes required to improve the quality of life for persons with dementia and neurodegenerative conditions and their caregivers."

News and events

Dementia Research Consensus Forum


DNNI and the Alzheimer Society of Ireland recently hosted a Dementia Research Consensus Forum on 10th April in Dublin. 

Headspace2018

Date:
Friday, 27 April, 2018 to Saturday, 28 April, 2018

DNNI (Dementia and Neurodegeneration Network Ireland), in collaboration with Creative Aging International and other partners are hosting Headspace2018 o

A Clinical Guide to Dementia - 1 Day Course


The Royal College of Physicians of Ireland are hosting a 1 day course (A Clinical Guide to Dementia) for doctors working in acute hospitals, community settings and general practice.

ASI - Alz Talks Channel


The ASI is very proud to share their AlzTalks You Tube channel.

Network focus

DNNI, by supporting multidisciplinary collaborative research and knowledge exchange, is dedicated to the enhancement of the understanding of the causes and mechanisms of dementia and neurodegeneration, the effectiveness of different models of care and the policy changes required to improve the quality of life for persons with dementia and neurodegenerative conditions and their caregivers.

The network strives to:

  • mobilise and capitalise on existing strengths to build scientific capacity within the network to integrate research evidence into practice and influence policy-making in the area of dementia and neurodegeneration
  • enhance inter-disciplinary and inter-institutional research co-operation and co-ordination across the island of Ireland
  • develop relationships between academics, practitioners and representatives of government, industry and the community and voluntary sector within Ireland and internationally
  • address the research and policy challenges faced by the dementia and neurodegenerative research community